Literature DB >> 17960151

Immunological and genetic bases of new primary immunodeficiencies.

László Maródi1, Luigi D Notarangelo.   

Abstract

Since 1952, when congenital agammaglobulinaemia was described by Bruton, the characterization of genetically defined immunodeficiencies in humans has been crucial for a better understanding of the biology of the innate and adaptive immune responses. This Review focuses on the characterization of new primary immunodeficiencies and disease-related genes. A series of primary defects of innate immunity have recently been discovered and are discussed here. Moreover, new defects in pre-B-cell and B-cell differentiation and antibody maturation are summarized and recently discovered monogenic immunodeficiencies that disturb the homeostasis of both the innate and the adaptive immune systems are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17960151     DOI: 10.1038/nri2195

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  18 in total

1.  Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies?

Authors:  László Maródi; Jean-Laurent Casanova
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

2.  Innate barriers against infection and associated disorders.

Authors:  Richard L Gallo; Victor Nizet
Journal:  Drug Discov Today Dis Mech       Date:  2008-06-01

Review 3.  The spread of the J Project.

Authors:  Zsuzsa Horváth; Nima Rezaei; Ismail Reisli; Irina Tuzankina; Nurzhan Otarbayev; Panteley Popandopulo; László Maródi
Journal:  J Clin Immunol       Date:  2013-05-19       Impact factor: 8.317

Review 4.  SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions.

Authors:  Cynthia Detre; Marton Keszei; Xavier Romero; George C Tsokos; Cox Terhorst
Journal:  Semin Immunopathol       Date:  2010-02-10       Impact factor: 9.623

5.  Transient glutathione depletion determines terminal differentiation in HL-60 cells.

Authors:  Suzanne M Krance; Peter C Keng; James Palis; Nazzareno Ballatori
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

6.  The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review.

Authors:  Rohan Ameratunga; See-Tarn Woon; Katherine Neas; Donald R Love
Journal:  Allergy Asthma Clin Immunol       Date:  2010-06-08       Impact factor: 3.406

Review 7.  Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species.

Authors:  László Maródi; Sophie Cypowyj; Beáta Tóth; Liudmyla Chernyshova; Anne Puel; Jean-Laurent Casanova
Journal:  J Allergy Clin Immunol       Date:  2012-10-03       Impact factor: 10.793

Review 8.  Therapeutic management of primary immunodeficiency in older patients.

Authors:  Nisha Verma; Anthony Thaventhiran; Benjamin Gathmann; James Thaventhiran; Bodo Grimbacher
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

9.  Prediction of candidate primary immunodeficiency disease genes using a support vector machine learning approach.

Authors:  Shivakumar Keerthikumar; Sahely Bhadra; Kumaran Kandasamy; Rajesh Raju; Y L Ramachandra; Chiranjib Bhattacharyya; Kohsuke Imai; Osamu Ohara; Sujatha Mohan; Akhilesh Pandey
Journal:  DNA Res       Date:  2009-10-03       Impact factor: 4.458

10.  Optimization of immunoglobulin substitution therapy by a stochastic immune response model.

Authors:  Marc Thilo Figge
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.